Management of Primary Pterygium with Intralesional Bevacizumab (AVASTIN) Injection
Objective: To determine the management of primary Pterygium with intralesional Bevacizumab (AVASTIN) Injection. Study Design: Quasi-Experimental Study Place and Duration of Study: Armed Forces Institute of Ophthalmology, Rawalpindi Pakistan, from ...
Irum Mahmood +5 more
doaj +1 more source
Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye [PDF]
Purpose: Dry eye is a chronic inflammatory ocular surface disease with high prevalence. The current therapies for dry eye remain to be unspecific and notcomprehensive.
Wang, Wei +5 more
core +1 more source
Comparison of the inhibitory effect of different doses of subconjunctival bevacizumab application in an experimental model of corneal neovascularization [PDF]
AIM: To evaluate the inhibitory effect of subconjunctival bevacizumab as single- and multiple-dose application, and compare their effects on corneal neovascularization in a rat model.
Burak Ulas +2 more
doaj +1 more source
Postoperative adjunctive bevacizumab versus placebo in primary trabeculectomy surgery for glaucoma [PDF]
AIM: To compare the effectiveness of postoperative adjunctive use of subconjunctival bevacizumab in altering the outcome of primary trabeculectomy in terms of sustained lowering of intraocular pressure (IOP) and reduction of postoperative bleb ...
Sana’ Muhsen +4 more
doaj +1 more source
Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer [PDF]
Objectives: Bevacizumab is a monoclonal antibody that directly inhibits vascular endothelial growth factor, a key regulator of angiogenesis. Bevacizumab significantly improves progression-free and/or overall survival in metastatic colorectal cancer in ...
Volker Heinemann +3 more
core +1 more source
Microenvironment‐responsive drug delivery systems overcome ocular physiological barriers by responding to temperature, pH, ions, reactive oxygen species, and enzymes. This review bridges material design, performance evaluation, and clinical translation, offering actionable insights for treating dry eye disease, infectious keratitis, and corneal ...
Jiamin Liu +3 more
wiley +1 more source
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
Corneal neovascularization (CNV) has a variety of causes and threatens corneal clarity, thus optimal visual acuity. Conventional medical management includes topical steroids and matrix metalloproteinase inhibitors like doxycycline.
Anna Krystyna Britton +1 more
doaj +1 more source
Bevacizumab as adjuvant therapy in the management of pterygium: a systematic review and Meta-analysis [PDF]
AIM: To evaluate the clinical effect of bevacizumab in pterygium treatment. METHODS: A systematic review and quantitative Meta-analysis was performed. PubMed, EMBASE, Web of Science and Cochrane database were searched for eligible literatures published ...
Jian Liu +7 more
doaj +1 more source
The outcome of preoperative subconjunctival bevacizumab injection in pterygium surgery
Objective The aim of this study was to evaluate the safety and the efficacy of subconjunctival injection of bevacizumab (Avastin) for the management of primary and recurrent pterygia and to estimate the recurrent rate of pterygia after surgery. Patients and methods The study included 60 eyes of 60 patients (45 male and 15 female), with a mean age of 41
AhmedS Mohamed +2 more
openaire +1 more source
PurposeTo evaluate the effects and underlying mechanisms of early and late subconjunctival injection of bevacizumab on the inhibition of corneal neovascularization (NV).MethodsCorneal NV was induced by closed eye contact lens wear followed by a silk ...
Wei-Li Chen +6 more
doaj +1 more source

